Imat 400 mg | Imatinib | for Blood Cancer Treatment

Introduction of Imat 400 mg

Imat 400 mg Tablet contains Imatinib Mesylate, a targeted cancer therapy used to treat various types of blood and gastrointestinal cancers. It belongs to a class of medications called tyrosine kinase inhibitors (TKIs), which work by blocking abnormal proteins that promote the growth of cancer cells.

Imat 400 mg is commonly prescribed for patients with Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GISTs). It is a cornerstone therapy for managing specific cancers with known genetic mutations, offering long-term control and improved survival rates.

✅ Key Uses of Imat 400 mg

• Treatment of Chronic Myeloid Leukemia (CML)
  
  

• Management of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  
  

• Used in treating Gastrointestinal Stromal Tumors (GISTs)
  
  

• Also effective in dermatofibrosarcoma protuberans (DFSP) and certain myelodysplastic disorders
  
  

✅ Common Side Effects

• Nausea, vomiting, or diarrhea
  
  

• Muscle cramps or joint pain
  
  

• Fluid retention (swelling)
  
  

• Skin rash
  
  

• Fatigue or weakness
  
  

✅ Precautions and Warnings

• Not recommended during pregnancy or breastfeeding unless clearly necessary
  
  

• Inform your doctor about any liver, kidney, or heart conditions
  
  

• Regular monitoring of blood counts and liver function is required
  
  

• Avoid alcohol and grapefruit products, which may interact with the drug
  
  

• Not intended for use in children unless prescribed
  
  

✅ Storage Instructions

• Store at room temperature (15–30°C)
  
  

• Protect from light, heat, and moisture
  
  

• Keep out of reach of children and pets